Trial Profile
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Jul 2012
Price :
$35
*
At a glance
- Drugs Resveratrol (Primary)
- Indications Cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 31 Jan 2007 New trial record.